TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

AKESO BIOPHARMA

OncologyGastroenterologyDermatology
Biotech

AKESO BIOPHARMA is a biotechnology company focused on Oncology, Gastroenterology, Dermatology.

2025
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PENPULIMAB-KCQX 2025-04-23
Type 1 - New Molecular Entity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 73%
1 drugs Phase 3: 24 Phase 2: 27 Phase 1: 41
Gastroenterology 8%
0 drugs Phase 3: 4 Phase 2: 1 Phase 1: 5
Dermatology 8%
0 drugs Phase 3: 3 Phase 2: 4 Phase 1: 1
Immunology 8%
0 drugs Phase 3: 3 Phase 2: 3 Phase 1: 3
Cardiovascular 3%
0 drugs Phase 2: 4 Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular, Gastroenterology
COSETTE other
Cardiovascular, Dermatology, Immunology, Oncology
Novartis big-pharma
Oncology, Cardiovascular, Immunology
Merck big-pharma
Oncology, Cardiovascular, Immunology